Park Medical Center, Witbank, South Africa Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2006
NCT00434291
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

Park Medical Centre, RSA

Active Ingredients

Drugs in Phase 2 Trials (1)

nemonoxacin (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 2)

Diabetic Foot (Phase 2)

Focal Infection (Phase 2)

Infections (Phase 2)

Pneumonia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1